AlphaYouGA
Schedule 13G filing
GENERAL ATLANTIC, L.P. disclosed a 6.8% stake in Korsana Biosciences, Inc. (KRSA)
GENERAL ATLANTIC, L.P. reported owning 6.8% of Korsana Biosciences, Inc. (KRSA) (3,201,131 shares) in a Schedule 13G filed Sep 18, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Sep 18, 2026
- Source
- Schedule 13G
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.